Mid and large-cap Chinese firms in semiconductors, AI and robotics are exploring Hong Kong IPOs, UBS executive says.

Hims & Hers Health beat fourth-quarter estimates and guided for better-than-expected revenue in the first quarter and 2025. The telehealth provider logged earnings of 11 cents a share on revenue of ...